Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte transfusion therapy

R G Strauss1

  • 1Department of Pathology and Pediatrics, University of Iowa College of Medicine, Iowa City.

Hematology/Oncology Clinics of North America
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

Vox sanguinis·2017
Same author

Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.

Vox sanguinis·2016
Same author

Education in transfusion medicine for medical students and doctors.

Vox sanguinis·2013
Same author

Preparation of granulocyte concentrates by apheresis: collection modalities in the USA.

Vox sanguinis·2011
Same author

Neonatal transfusions.

Vox sanguinis·2009
Same author

The future use of pathogen-inactivated platelet concentrates.

Vox sanguinis·2003

Therapeutic granulocyte transfusions show promise for severe infections in neutropenic patients. Recombinant granulocyte colony-stimulating factor may enable adequate granulocyte collection, warranting reassessment of this therapy.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Transfusion Medicine

Background:

  • Therapeutic granulocyte transfusions are effective for severe infections in neutropenic patients.
  • Limited acceptance is due to difficulties in transfusing adequate, compatible granulocyte doses.
  • Recent advancements offer potential for increased granulocyte collection.

Purpose of the Study:

  • To reassess the therapeutic role of granulocyte transfusions.
  • To evaluate granulocyte transfusions for bacterial, yeast, and fungal infections.
  • To consider the impact of recombinant granulocyte colony-stimulating factor on granulocyte collection.

Main Methods:

  • Literature review on granulocyte transfusion efficacy.
  • Analysis of methods for enhancing granulocyte collection.

Related Experiment Videos

  • Assessment of clinical scenarios for granulocyte transfusion therapy.

    • Main Results:

    • Efficacy of granulocyte transfusions is supported by existing literature.
    • Recombinant granulocyte colony-stimulating factor can significantly increase granulocyte yield.
    • Improved collection methods may overcome previous limitations.

    Conclusions:

    • Granulocyte transfusions are a viable option for severe infections in neutropenia.
    • Enhanced granulocyte collection warrants a re-evaluation of transfusion protocols.
    • This therapy holds potential for treating progressive bacterial, yeast, and fungal infections.